Metabolic Acidosis in Lactic Acidosis Suggestive of Metformin Poisoning
Clinical Scenario
This protocol targets patients who develop metabolic acidosis in the setting of lactic acidosis arising during metformin treatment — a presentation with specific diagnostic criteria and a defined clinical pathway.
Characterised by arterial lactate above 5 mmol/L and pH below 7.35 during metformin treatment.
Key Condition: Lactic Acidosis
Metformin-associated lactic acidosis carries specific clinical decision points: the presence of organ dysfunction, or the absence of meaningful improvement within the first hours of initial management, are critical triggers that shape the intervention strategy.
Management Approach
Early renal replacement therapy is a central component of the approach in this setting — the complete protocol specifies the criteria, timing, and supporting framework beyond what is outlined here.
References
DOI: 10.1053/j.ajkd.2019.01.036
- Metformin-associated lactic acidosis is defined by arterial lactate above 5 mmol/L and pH below 7.35 during metformin treatment.
- In case of lactic acidosis suggestive of metformin poisoning, the experts suggest early initiation of renal replacement therapy when there is an organ dysfunction or in the absence of improvement in the first hours of therapeutic management (EXPERT OPINION).
- Renal replacement therapy is intended to correct water–electrolyte and acid–base disturbances and to ensure metformin clearance.
View source ↗